155 related articles for article (PubMed ID: 20972736)
21. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.
Bahlmann FH; de Groot K; Mueller O; Hertel B; Haller H; Fliser D
Hypertension; 2005 Apr; 45(4):526-9. PubMed ID: 15767470
[TBL] [Abstract][Full Text] [Related]
22. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
[TBL] [Abstract][Full Text] [Related]
23. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.
Jennings PE; Belch JJ
Metabolism; 2000 Feb; 49(2 Suppl 1):23-6. PubMed ID: 10693916
[TBL] [Abstract][Full Text] [Related]
24. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.
Dhindsa P; Davis KR; Donnelly R
Br J Clin Pharmacol; 2003 Jun; 55(6):616-9. PubMed ID: 12814458
[TBL] [Abstract][Full Text] [Related]
26. Evaluation approach can significantly influence oral glucose-lowering drugs total mortality risks in retrospective cohorts of type 2 diabetes mellitus patients.
Khalangot M; Kovtun V
Curr Diabetes Rev; 2014; 10(5):336-42. PubMed ID: 25336066
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
Cho HY; Yoon H; Lim YC; Lee YB
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
[TBL] [Abstract][Full Text] [Related]
28. Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents.
Furlong NJ; Hulme SA; O'Brien SV; Hardy KJ
Diabet Med; 2003 Nov; 20(11):935-41. PubMed ID: 14632720
[TBL] [Abstract][Full Text] [Related]
29. Expression of miR-210 in the peripheral blood of patients with newly diagnosed type 2 diabetes mellitus and its effect on the number and function of endothelial progenitor cells.
Li X; Jia Z; Zhao X; Xu M; Chen M
Microvasc Res; 2020 Sep; 131():104032. PubMed ID: 32533960
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
[TBL] [Abstract][Full Text] [Related]
31. Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records.
Polavarapu NK; Kale R; Sethi B; Sahay RK; Phadke U; Ramakrishnan S; Mane A; Mehta S; Shah S
Drugs Real World Outcomes; 2020 Dec; 7(4):271-279. PubMed ID: 32648242
[TBL] [Abstract][Full Text] [Related]
32. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.
Yu JW; Deng YP; Han X; Ren GF; Cai J; Jiang GJ
Cardiovasc Diabetol; 2016 Jun; 15():88. PubMed ID: 27316923
[TBL] [Abstract][Full Text] [Related]
33. Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.
Al-Gareeb AI; Alrubai HF; Suliaman SM
Indian J Endocrinol Metab; 2016; 20(2):195-8. PubMed ID: 27042415
[TBL] [Abstract][Full Text] [Related]
34. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L
Diabetes Res Clin Pract; 2015 Jan; 107(1):104-12. PubMed ID: 25458330
[TBL] [Abstract][Full Text] [Related]
35. The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.
Hsu CH; Liao YL; Lin SC; Hwang KC; Chou P
J Altern Complement Med; 2007; 13(1):97-102. PubMed ID: 17309383
[TBL] [Abstract][Full Text] [Related]
36. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
Tai H; Wang MY; Zhao YP; Li LB; Dong QY; Liu XG; Kuang JS
Medicine (Baltimore); 2016 Aug; 95(33):e4541. PubMed ID: 27537577
[TBL] [Abstract][Full Text] [Related]
37. [Medication of the month. Gliclazide modified release (Uni Diamicron)].
Scheen AJ
Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus.
Hamed S; Brenner B; Aharon A; Daoud D; Roguin A
Cardiovasc Diabetol; 2009 Oct; 8():56. PubMed ID: 19878539
[TBL] [Abstract][Full Text] [Related]
39. The potential hepatoprotective effects of lovastatin combined with oral hypoglycemic agents in streptozotocin-induced diabetes in rats.
Sharkawi SMZ; El-Shoura EAM; Abo-Youssef AM; Hemeida RAM
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):165-173. PubMed ID: 32114843
[No Abstract] [Full Text] [Related]
40. Poor outcome of experimental ischemic stroke in type 2 diabetic rats: impaired circulating endothelial progenitor cells mobilization.
Yang H; Ma S; Liu Y; Li Y; Wu W; Han E; Jia G; Wang C
J Stroke Cerebrovasc Dis; 2015 May; 24(5):980-7. PubMed ID: 25813059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
